Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.320
-0.060 (-2.52%)
At close: Nov 20, 2026, 4:00 PM EST
2.300
-0.020 (-0.86%)
After-hours: Nov 20, 2026, 4:38 PM EST
Boundless Bio Employees
Boundless Bio had 28 employees as of December 31, 2025. The number of employees decreased by 36 or 56.25% compared to the previous year. That makes Boundless Bio the 37,344th largest employer in the world and 5,197th in the United States.
Employees
28
Change (1Y)
-36
Growth (1Y)
-56.25%
Revenue / Employee
n/a
Profits / Employee
-$1,982,036
Market Cap
54.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | -36 | -56.25% |
| Dec 31, 2024 | 64 | -8 | -11.11% |
| Mar 31, 2024 | 72 | 0 | - |
| Dec 31, 2023 | 72 | - | - |
| Sep 30, 2023 | 71 | - | - |
| Jun 30, 2023 | 72 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| XBiotech | 87 |
| Fortress Biotech | 78 |
| Xilio Therapeutics | 76 |
| Acrivon Therapeutics | 76 |
| Milestone Pharmaceuticals | 38 |
| iBio, Inc. | 23 |
| Cognition Therapeutics | 14 |
BOLD News
- 10 days ago - Boundless Bio Quarterly report: Q3 2026 - Filings
- 2 months ago - Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Names Senior Leadership Team to Advance Potential Best-in-Class in vivo Base Editing Program for Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 2 months ago - Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer - GlobeNewsWire
- 3 months ago - Boundless Bio Quarterly report: Q2 2026 - Filings
- 4 months ago - Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 5 months ago - Boundless Bio, Serapha Bio to combine in all-stock merger - TheFly
- 5 months ago - Boundless Bio Transcript: M&A announcement - Transcripts
- 5 months ago - Boundless Bio Press release: M&A announcement - Filings